Report Detail

Pharma & Healthcare Global EPA / DHA/ALA (Omega 3) Market Research Report 2021

  • RnM3973587
  • |
  • 22 March, 2021
  • |
  • Global
  • |
  • 93 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Fish Oil
Algae Oil

Segment by Application
Dietary Supplements
Functional Foods & Beverages
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma
GC Rieber
Polaris
Auqi


1 EPA / DHA/ALA (Omega 3) Market Overview

  • 1.1 Product Overview and Scope of EPA / DHA/ALA (Omega 3)
  • 1.2 EPA / DHA/ALA (Omega 3) Segment by Type
    • 1.2.1 Global EPA / DHA/ALA (Omega 3) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Fish Oil
    • 1.2.3 Algae Oil
  • 1.3 EPA / DHA/ALA (Omega 3) Segment by Application
    • 1.3.1 EPA / DHA/ALA (Omega 3) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Dietary Supplements
    • 1.3.3 Functional Foods & Beverages
    • 1.3.4 Others
  • 1.4 Global EPA / DHA/ALA (Omega 3) Market Size Estimates and Forecasts
    • 1.4.1 Global EPA / DHA/ALA (Omega 3) Revenue 2016-2027
    • 1.4.2 Global EPA / DHA/ALA (Omega 3) Sales 2016-2027
    • 1.4.3 EPA / DHA/ALA (Omega 3) Market Size by Region: 2016 Versus 2021 Versus 2027

2 EPA / DHA/ALA (Omega 3) Market Competition by Manufacturers

  • 2.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global EPA / DHA/ALA (Omega 3) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers EPA / DHA/ALA (Omega 3) Manufacturing Sites, Area Served, Product Type
  • 2.5 EPA / DHA/ALA (Omega 3) Market Competitive Situation and Trends
    • 2.5.1 EPA / DHA/ALA (Omega 3) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest EPA / DHA/ALA (Omega 3) Players Market Share by Revenue
    • 2.5.3 Global EPA / DHA/ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 EPA / DHA/ALA (Omega 3) Retrospective Market Scenario by Region

  • 3.1 Global EPA / DHA/ALA (Omega 3) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global EPA / DHA/ALA (Omega 3) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
    • 3.3.1 North America EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.3.2 North America EPA / DHA/ALA (Omega 3) Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
    • 3.4.1 Europe EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.4.2 Europe EPA / DHA/ALA (Omega 3) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific EPA / DHA/ALA (Omega 3) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific EPA / DHA/ALA (Omega 3) Sales by Region
    • 3.5.2 Asia Pacific EPA / DHA/ALA (Omega 3) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
    • 3.6.1 Latin America EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.6.2 Latin America EPA / DHA/ALA (Omega 3) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.7.2 Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global EPA / DHA/ALA (Omega 3) Historic Market Analysis by Type

  • 4.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2016-2021)
  • 4.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Type (2016-2021)
  • 4.3 Global EPA / DHA/ALA (Omega 3) Price by Type (2016-2021)

5 Global EPA / DHA/ALA (Omega 3) Historic Market Analysis by Application

  • 5.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2016-2021)
  • 5.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Application (2016-2021)
  • 5.3 Global EPA / DHA/ALA (Omega 3) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 EPAX
    • 6.1.1 EPAX Corporation Information
    • 6.1.2 EPAX Description and Business Overview
    • 6.1.3 EPAX EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 EPAX Product Portfolio
    • 6.1.5 EPAX Recent Developments/Updates
  • 6.2 Golden Omega
    • 6.2.1 Golden Omega Corporation Information
    • 6.2.2 Golden Omega Description and Business Overview
    • 6.2.3 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Golden Omega Product Portfolio
    • 6.2.5 Golden Omega Recent Developments/Updates
  • 6.3 TASA
    • 6.3.1 TASA Corporation Information
    • 6.3.2 TASA Description and Business Overview
    • 6.3.3 TASA EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 TASA Product Portfolio
    • 6.3.5 TASA Recent Developments/Updates
  • 6.4 Omega Protein
    • 6.4.1 Omega Protein Corporation Information
    • 6.4.2 Omega Protein Description and Business Overview
    • 6.4.3 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Omega Protein Product Portfolio
    • 6.4.5 Omega Protein Recent Developments/Updates
  • 6.5 Croda
    • 6.5.1 Croda Corporation Information
    • 6.5.2 Croda Description and Business Overview
    • 6.5.3 Croda EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Croda Product Portfolio
    • 6.5.5 Croda Recent Developments/Updates
  • 6.6 KD Pharma
    • 6.6.1 KD Pharma Corporation Information
    • 6.6.2 KD Pharma Description and Business Overview
    • 6.6.3 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 KD Pharma Product Portfolio
    • 6.6.5 KD Pharma Recent Developments/Updates
  • 6.7 GC Rieber
    • 6.6.1 GC Rieber Corporation Information
    • 6.6.2 GC Rieber Description and Business Overview
    • 6.6.3 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 GC Rieber Product Portfolio
    • 6.7.5 GC Rieber Recent Developments/Updates
  • 6.8 Polaris
    • 6.8.1 Polaris Corporation Information
    • 6.8.2 Polaris Description and Business Overview
    • 6.8.3 Polaris EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Polaris Product Portfolio
    • 6.8.5 Polaris Recent Developments/Updates
  • 6.9 Auqi
    • 6.9.1 Auqi Corporation Information
    • 6.9.2 Auqi Description and Business Overview
    • 6.9.3 Auqi EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Auqi Product Portfolio
    • 6.9.5 Auqi Recent Developments/Updates

7 EPA / DHA/ALA (Omega 3) Manufacturing Cost Analysis

  • 7.1 EPA / DHA/ALA (Omega 3) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of EPA / DHA/ALA (Omega 3)
  • 7.4 EPA / DHA/ALA (Omega 3) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 EPA / DHA/ALA (Omega 3) Distributors List
  • 8.3 EPA / DHA/ALA (Omega 3) Customers

9 EPA / DHA/ALA (Omega 3) Market Dynamics

  • 9.1 EPA / DHA/ALA (Omega 3) Industry Trends
  • 9.2 EPA / DHA/ALA (Omega 3) Growth Drivers
  • 9.3 EPA / DHA/ALA (Omega 3) Market Challenges
  • 9.4 EPA / DHA/ALA (Omega 3) Market Restraints

10 Global Market Forecast

  • 10.1 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Type (2022-2027)
  • 10.2 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Application (2022-2027)
  • 10.3 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on EPA / DHA/ALA (Omega 3). Industry analysis & Market Report on EPA / DHA/ALA (Omega 3) is a syndicated market report, published as Global EPA / DHA/ALA (Omega 3) Market Research Report 2021. It is complete Research Study and Industry Analysis of EPA / DHA/ALA (Omega 3) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,296.80
    3,445.20
    4,593.60
    2,679.60
    4,019.40
    5,359.20
    438,741.00
    658,111.50
    877,482.00
    241,773.00
    362,659.50
    483,546.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report